BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.96 and traded as low as $1.55. BioRestorative Therapies shares last traded at $1.62, with a volume of 13,195 shares trading hands.
BioRestorative Therapies Stock Performance
The firm has a market capitalization of $12.25 million, a price-to-earnings ratio of -1.16 and a beta of 64.37. The stock’s fifty day moving average is $1.97 and its two-hundred day moving average is $1.71.
About BioRestorative Therapies
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- How to Read Stock Charts for Beginners
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How Investors Can Find the Best Cheap Dividend Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
